Clinical Trial Update: Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Endoxifen for Bipolar I Disorder; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Endoxifen (Endoxifen)

Snippet

Sponsor: Jina Pharmaceuticals Inc. | Conditions: Bipolar 1 Disorder | Phase 3 | Status: ACTIVE_NOT_RECRUITING